Ohio State Medical Oncology (@ohiostatemedonc) 's Twitter Profile
Ohio State Medical Oncology

@ohiostatemedonc

The OSU Division of Medical Oncology: providing cutting-edge compassionate care through team science to those diagnosed with solid tumor malignancies

ID: 1616548109991161857

linkhttps://go.osu.edu/CVrQ calendar_today20-01-2023 21:28:14

898 Tweet

554 Followers

592 Following

Ohio State Medical Oncology (@ohiostatemedonc) 's Twitter Profile Photo

🎉Congrats to Amir Mortazavi on his appointment to the honorary Mazzaferri-Ellison Society of Master Clinicians, which recognizes outstanding clinicians who excel in clinical practice, clinical teaching, mentoring/role modeling, professionalism, leadership & service to The Ohio State University Wexner Medical Center

🎉Congrats to Amir Mortazavi on his appointment to the honorary Mazzaferri-Ellison Society of Master Clinicians, which recognizes outstanding clinicians who excel in clinical practice, clinical teaching, mentoring/role modeling, professionalism, leadership &amp; service to <a href="/OSUWexMed/">The Ohio State University Wexner Medical Center</a>
Ohio State Medical Oncology (@ohiostatemedonc) 's Twitter Profile Photo

📝New publication from Dr. Steven Clinton & colleagues: Integration of genetic counselling into a multidisciplinary urological oncology programme enhances access and detection of hereditary prostate cancer syndromes doi.org/10.1136/jmg-20…

DAVA Oncology (@davaonc) 's Twitter Profile Photo

Early-stage lung cancer detection strategy! Dr.Logan Roof, MD, MS of The Ohio State University Wexner Medical Center details the Lung Nodule Clinic model—>60 lung cancers dx’d in Y1, 40+ early-stage cases received curative treatment; AI triage projected to 2× volume. MDT + centralized intake key. #DAVALung #LungCancer

Early-stage lung cancer detection strategy! Dr.<a href="/LoganRoofMD/">Logan Roof, MD, MS</a>  of <a href="/OSUWexMed/">The Ohio State University Wexner Medical Center</a> details the Lung Nodule Clinic model—&gt;60 lung cancers dx’d in Y1, 40+ early-stage cases received curative treatment; AI triage projected to 2× volume. MDT + centralized intake key. #DAVALung #LungCancer
Alessandro Russo (@al3ssandrorusso) 's Twitter Profile Photo

A great lecture of Prof. Christian Rolfo at the #Fonicap consensus conference here at the International School of Medical Sciences in Erice 🇮🇹 Thanks for your invaluable contribution and support. International Society of Liquid Biopsy

A great lecture of Prof. <a href="/ChristianRolfo/">Christian Rolfo</a> at the #Fonicap consensus conference here at the International School of Medical Sciences in Erice 🇮🇹 
Thanks for your invaluable contribution and support. <a href="/isliquidbiopsy/">International Society of Liquid Biopsy</a>
Christine Garcia, MD, MPH (@christinemphmd) 's Twitter Profile Photo

“Old does not = frail.” Dr. Carolyn Presley Carolyn Presley, MD MHS discusses the design of the ACHIEVE study, emphasizing the inclusion of older adults, at DAVA Oncology #HawaiiLung25 #GeriOnc

“Old does not = frail.” Dr. Carolyn Presley <a href="/CPresGeriOncMD/">Carolyn Presley, MD MHS</a> discusses the design of the ACHIEVE study, emphasizing the inclusion of older adults, at <a href="/DAVAOnc/">DAVA Oncology</a> #HawaiiLung25 #GeriOnc
Ohio State Medical Oncology (@ohiostatemedonc) 's Twitter Profile Photo

📝New publication from Dr. David Carbone & colleagues: Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA ESMO Open The James #NSCLC doi.org/10.1016/j.esmo…

Journal of Clinical Investigation (@jclinicalinvest) 's Twitter Profile Photo

ICYMI: Vaccines in cancer treatment and prevention: the time is now: jci.org/articles/view/… In this viewpoint, William Becker & Kimryn Rathmell suggest that cutting‑edge mRNA neoantigen-based vaccines can train the immune system to better detect and eliminate cancer cells.

ICYMI: 
Vaccines in cancer treatment and prevention: the time is now: jci.org/articles/view/… 

In this viewpoint, William Becker &amp; <a href="/KimrynRathmell/">Kimryn Rathmell</a> suggest that cutting‑edge mRNA neoantigen-based vaccines can train the immune system to better detect and eliminate cancer cells.
Ohio State Medical Oncology (@ohiostatemedonc) 's Twitter Profile Photo

📝New publication from Dr. Sameek Roychowdhury & colleagues: Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers npj Journals doi.org/10.1038/s41698…

Nerea Lopetegui-Lia, MD (@nerealiamd) 's Twitter Profile Photo

🚴‍♀️On 8/2, I’ll be cycling 50 miles with Pelotonia to raise funds for cancer research. 💯% of donations go directly to research #EndingCancer #OneGoal Please consider supporting my ride pelotonia.org/profile/NL9672…

Ohio State Medical Oncology (@ohiostatemedonc) 's Twitter Profile Photo

Read more about a new clinical trial using a drug developed at The James. JBZ-001 is licensed to a commercial partner, Jabez Biosciences, which is working with Asrar AlAhmadi, MD, MAS-CR - أسرار الأحمدي, trial PI. health.osu.edu/health/cancer/…

The James (@osuccc_james) 's Twitter Profile Photo

Join Ohio State experts to learn about the latest in oncology innovation at our 2025 ASCO review, 7/12 in Columbus. Click for info/registration: go.osu.edu/C6qH

Join Ohio State experts to learn about the latest in oncology innovation at our 2025 ASCO review, 7/12 in Columbus. Click for info/registration: go.osu.edu/C6qH